Preview

Вестник трансплантологии и искусственных органов

Расширенный поиск

МОРФОЛОГИЧЕСКИЕ ОСОБЕННОСТИ ПОЗДНЕГО ОТТОРЖЕНИЯ ТРАНСПЛАНТИРОВАННОЙ ПОЧКИ И ИХ ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ

https://doi.org/10.15825/1995-1191-2014-2-30-38

Полный текст:

Об авторах

Е.С. Столяревич
Отделение нефрологических проблем трансплантации почки ФГБУ «ФНЦ трансплантологии и искусственных органов им. академика В.И. Шумакова» МЗ РФ, Москва, Кафедра нефрологии факультета постдипломного образования Московского государственного медико-стоматологического университета, Москва, ГКБ № 52, Москва
Россия


Л.Ю. Артюхина
ГКБ № 52, Москва
Россия


И.Г. Ким
Отделение нефрологических проблем трансплантации почки ФГБУ «ФНЦ трансплантологии и искусственных органов им. академика В.И. Шумакова» МЗ РФ, Москва, ГКБ № 52, Москва
Россия


Л.Г. Куренкова
Отделение патологической анатомии ФГБУ «ФНЦ трансплантологии и искусственных органов им. академика В.И. Шумакова» МЗ РФ, Москва,
Россия


Н.А. Томилина
Отделение нефрологических проблем трансплантации почки ФГБУ «ФНЦ трансплантологии и искусственных органов им. академика В.И. Шумакова» МЗ РФ, Москва, Кафедра нефрологии факультета постдипломного образования Московского государственного медико-стоматологического университета, Москва, ГКБ № 52, Москва
Россия


Список литературы

1. Gaston R.S., Cecka J.M., Kasiske B.L. et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation. 2010 Jul 15; 90 (1): 68–74.

2. Gourishankar S., Leduc R., Connett J. et al. Pathological and clinical characterization of the «troubled transplant »: data from the DeKAF study. Am J Transplant. 2010 Feb; 10 (2): 324–330.

3. Racusen L.C., Solez K., Colvin R.B. et al. The Banff 97 working classifi cation of renal allograft pathology. Kidney Int. 1999; 55: 713–723.

4. Feucht H.E., Schneeberger H., Hillebrand G. et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int. 1993; 43: 1333–1338.

5. Collins A.B., Schneeberger E.E., Pascual M.A. et al. Complement activation in acute humoral renal allograft rejection: Signifi cance of C4d deposits in peritubular capillaries. J Am Soc Nephrol. 1999; 10: 2208–2214, 81.

6. Mauiyyedi S., Crespo M., Collins A.B., Schneeberger E.E., Pascual M.A., Saidman S.L. et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classifi cation. J Am Soc Nephrol. 2002; 13: 779–787, 216.

7. Racusen L.C., Colvin R.B., Solez K. et al. Antibodymediated rejection criteria – an addition to the Banff 97 classifi cation of renal allograft rejection. Am J Transplant. 2003; 6: 708–714 309.

8. Sis B., Mengel M., Haas M. et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant. 2010 Mar; 10 (3): 464–471.

9. Colvin R.B. Renal transplant pathology. In: Heptinstall’s Pathology of the Kidney, 5th Ed. / ed. by Jennette J.C., Olson J.C., Schwartz M.L., Silva F.G. Philadelphia: Lippincott-Raven Publishers, 1998: 1409–1540.

10. Mauiyyedi S., Pelle P.D., Saidman S. et al. Chronic humoral rejection: identifi cation of antibody-mediated chronic renal allograft rejection by C4d deposition in peritubular capillaries. J Am Soc Nephrol. 2001: 12: 574.

11. Nankivell B.J., Alexander S.I. Rejection of the Kidney Allograft. N Engl J Med. 2010; 363: 1451–1462.

12. Nickeleit V., Andreoni K. The classifi cation and treatment of antibody-mediated renal allograft injury: Where do we stand? Kidney Int. 2007; 71: 7–11.

13. Rotmans S., Collins A.B., Colvin R.B. et al. C4d deposition in allograft: current concepts and interpretation. Transplantation reviews. 2005; 19: 65–72.

14. Crespo M., Pascual M., Tolkoff-Rubin N. et al. Acute humoral rejection in renal allograft recipients: Incidence, serology, and clinical characteristics. Transplantation. 2001; 5: 652–658.

15. Herzenberg A.M., Gill J.S., Djurdjev O., Magil A.B. C4d deposition in acute rejection: An independent long-term prognostic factor. J Am Soc Nephrol. 2002; 13: 234–241.

16. Regele H., Exner M., Watschinger B. et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant. 2001; 16: 2058–2066.

17. Wang R., Wang H., Chen J. et al. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure. Nephrology. 2009; 5: 527–532.

18. Haas M. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Clinical Nephrology. 2011; 75 (4): 271–278.

19. Sis B. Campbell P.M., Mueller T. et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant. 2007 Jul; 7 (7): 1743–1752.

20. Ciszek M., Ptasińska A.P., Durlik M. et al. C4d-positive renal transplants: single-center clinical outcomes. Clin Transpl. 2006; 1: 405–412.

21. Kedainis R.L., Koch M.J., Brennan D.C., Liapis H. Focal C4d+ in renal allografts is associated with the presence of donor specifi c antibodies and decreased allograft survival. Am J Transplant. 2009 April; 9 (4): 812–819.

22. Pefaur J., Diaz P., Panace R. et al. Early and late humoral rejection: a clinicopathologic entity in two times. Transplant Proc. 2008; 9: 3229–3236.

23. Poduval R.D., Kadambi P.V., Josephson M.A. et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 2005; 79: 225.

24. Mengel M., Bogers J., Bosmans J.L., Seron D., Moreso F., Carrera M. et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant. 2005; 5: 1050–1056.

25. Nickeleit V., Zeiler M., Gudat F. et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol. 2002; 13: 242–251.

26. Satoskar A.A., Lehman A.M., Nadasdy G.M. et al. Peritubular capillary C4d staining in late acute renal allograft rejection-is it relevant? Clin Transplant. 2008; 1: 61–67.

27. Kieran N., Wang X., Perkins J. et al. Combination of peritubular C4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol. 2009 October; 20 (10): 2260–2268.

28. Haas M. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum. Curr Opin Nephrol Hypertens. 2012 May; 21 (3): 264–271.

29. Sis B., Jhangri G.S., Bunnag S. Endothelial gene expression in kidney transplants with alloantibody indicates Antibody-mediated damage despite lack of C4d staining. Am J Transplant. 2009; 9 (10): 2312–2323.

30. Loupy A., Hill G.S., Suberbielle C. et al. Signifi cance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specifi c antibodies (DSA). Am J Transplant. 2011 Jan; 11 (1): 56–65.

31. Miura M., Harada H., Fukasawa Y. Long-term histopathology of allografts in sensitized kidney recipients. Clin Transplant. 2012 Jul; 26 Suppl 24: 32–36.

32. Magil A.B., Tinckam K.J. Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant. 2006; 21: 1382–1388.

33. Smith R.N., Kawai T., Boskovic S. et al. Chronic antibody mediated rejection of renal allografts: Pathological, serological, and immunologic features in nonhuman primates. Am J Transplant. 2006; 6: 1790–1798.

34. Regele H., Bohmig G.A., Habicht A. et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol. 2002; 13: 2371–2380.

35. Gloor J.M., Sethi S., Stegall M.D. Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody. Am J Transplant. 2007 September; 7 (9): 2124–2132.

36. Vongwiwatana A., Gourishankar S., Campbell P.M. et al. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant. 2004; 4: 124–129.

37. Racusen L. Chronic transplant glomerulopathy: need for further assessment. Clin J Am Soc Nephrol. 2007 Nov; 2 (6): 1108–1109. Epub 2007 Oct 17.

38. Hidalgo L.G., Sis B., Sellares J., Campbell P.M. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specifi c antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant. 2010 Aug; 10 (8): 1812–1822.

39. Plissonier D., Henaff M., Poncet P. et al. Involvement of antibody-dependent apoptosis in graft rejection. Transplantation. 2000; 69: 2601–2608.

40. David-Neto E., Prado E., Beutel A. et al. C4d-positive chronic rejection: A frequent entity with a poor outcome. Transplantation. 2007; 84: 1391–1398.

41. Cosio F.G., Grande J.P., Wadei H. et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant. 2005; 5: 2464–2472.

42. Suri D.L., Tomlanovich S.J., Olson J.L., Meyer T.W. Transplant glomerulopathy as a cause of late graft loss. Am J Kidney Dis. 2000 Apr; 35 (4): 674–680.

43. Shimizu T., Tanabe T., Shirakawa H. et al. Clinical and pathological analysis of transplant glomerulopathy cases.

44. Clin Transplant. 2012: 26 (Suppl. 24): 37–42.


Рецензия

Для цитирования:


Столяревич Е., Артюхина Л., Ким И., Куренкова Л., Томилина Н. МОРФОЛОГИЧЕСКИЕ ОСОБЕННОСТИ ПОЗДНЕГО ОТТОРЖЕНИЯ ТРАНСПЛАНТИРОВАННОЙ ПОЧКИ И ИХ ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ. Вестник трансплантологии и искусственных органов. 2014;16(2):30-38. https://doi.org/10.15825/1995-1191-2014-2-30-38

For citation:


Stolyarevich E., Artyukhina L., Kim I., Kurenkova L., Tomilina N. LATE RENAL GRAFT REJECTION: PATHOLOGY AND PROGNOSIS. Russian Journal of Transplantology and Artificial Organs. 2014;16(2):30-38. (In Russ.) https://doi.org/10.15825/1995-1191-2014-2-30-38

Просмотров: 1730


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)
ISSN 2412-6160 (Online)